ROYA YAZDANI: Open Payments
NPI 1932483062 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$135 in 6 payments from 5 companies in 2025. Trend: 2023 $220 · 2024 $291 · 2025 $135
Food & beverage: $135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $40 |
| Astellas Pharma US Inc | 1 | $34 |
| PFIZER INC. | 1 | $22 |
| ViiV Healthcare Company | 1 | $21 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
Products named: Cresemba, AVYCAZ, ELIQUIS, DOVATO, VIBATIV, DALVANCE.
Industry payments across TX — which companies pay providers there.
